StonvexLoading…
StonvexStonvexStonvexCore line items from BUKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $83.97M | $78.38M | $75.18M | $71.52M |
Operating Income | $16.83M | $13.24M | $8.65M | $16.13M |
Net Income | $12.55M | $12.51M | $4.52M | $10.37M |
EPS (Diluted) | $0.19 | $0.18 | $0.06 | $0.14 |
Total Assets | $123.30M | $113.97M | $113.91M | $100.81M |
Total Liabilities | $58.18M | $59.53M | $67.13M | $59.98M |
Cash & Equivalents | $25.23M | $17.79M | $22.00M | $12.49M |
Free Cash Flow OCF − CapEx | $10.14M | $-1.20M | $14.43M | $1.60M |
Shares Outstanding | 67.18M | 68.77M | 76.89M | 76.46M |